Huachansu Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Huachansu Tablet, covering 2024-08-07 to 2024-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) [Phase 3]